4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)morpholine, 95.0%, 5g

Dodecylmethylsiloxane-hydroxypolylalkyleneoxypropylmethylsiloxane, copolymer cSt 1000-4000, 100g

6,7-Dihydro-5H-cyclopenta[b]pyridine 1-oxide, 95.0%, 250mg

(3,5-Dimethylphenyl)methanol, 95.0%, 25g

3,5-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98+%, 100mg

4-(2-Methoxy-2-oxoethoxy)benzoic acid, 95%, 500mg

(2,4-Dioxo-3,4-dihydro-2 H -pyrimidin-1-yl)-acetic acid, 95.0%, 25g

5-ethyl-1,3,4-oxadiazol-2-ol, 95.0%, 250mg

(S)-methyl 2-((tert-butoxycarbonyl)amino)-3-(4-carbamoyl-2,6-dimethylphenyl)propanoate, 96%, 100mg

5-Amino-2,4-di-tert-butylphenyl methyl carbonate, 95%, 10g

4-Nitroguaiacol, 98.0%, 25g

5-Nitro-2-piperazin-1-yl-benzoic acid methyl ester, 98.0%, 1g

METHYL 3-(CYANOMETHYL)-4-NITROBENZOATE, 95.0%, 1g